Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,032 | 4,707 | 16,219 | 2,228 | 3,329 |
| Marketable Securities | 38,015 | 40,405 | 31,878 | 19,067 | 20,072 |
| Receivables | 168 | 130 | 104 | 16 | 337 |
| Other current assets | 103 | 0 | 0 | 0 | 0 |
| TOTAL | $42,111 | $45,439 | $48,537 | $21,629 | $24,195 |
| Non-Current Assets | |||||
| PPE Net | 74 | 70 | 70 | 73 | 75 |
| Other Non-Current Assets | 26 | 42 | 57 | 72 | 86 |
| TOTAL | $100 | $112 | $127 | $145 | $161 |
| Total Assets | $42,211 | $45,551 | $48,664 | $21,774 | $24,356 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 433 | 509 | 699 | 239 | 689 |
| Accrued Expenses | 967 | 966 | 861 | 1,132 | 420 |
| TOTAL | $1,434 | $1,524 | $1,624 | $1,440 | $1,178 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 11 | 28 |
| TOTAL | $9 | $3 | $4 | $16 | $33 |
| Total Liabilities | $1,443 | $1,527 | $1,628 | $1,456 | $1,211 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,443 | 26,443 | 26,439 | 18,786 | 18,786 |
| Retained earnings | -86,009 | -82,501 | -79,255 | -75,805 | -72,531 |
| Other shareholders' equity | -107 | -51 | -5 | -3 | -4 |
| TOTAL | $40,768 | $44,024 | $47,036 | $20,318 | $23,145 |
| Total Liabilities And Equity | $42,211 | $45,551 | $48,664 | $21,774 | $24,356 |